olmesartan has been researched along with Glomerulonephritis, IGA in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Katsurada, A; Kobori, H; Miyata, K; Ohashi, N; Saito, T; Satou, R; Urushihara, M | 1 |
| Inoue, T; Kawagoe, Y; Koide, H; Nakamura, T; Node, K; Sugaya, T; Suzuki, T; Ueda, Y | 1 |
1 trial(s) available for olmesartan and Glomerulonephritis, IGA
| Article | Year |
|---|---|
Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid-binding protein levels in normotensive patients with immunoglobin A nephropathy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Deoxyguanosine; Double-Blind Method; Drug Therapy, Combination; Fatty Acid-Binding Proteins; Female; Glomerulonephritis, IGA; Heart Rate; Humans; Imidazoles; Male; Proteinuria; Tetrazoles; Thiazepines | 2007 |
1 other study(ies) available for olmesartan and Glomerulonephritis, IGA
| Article | Year |
|---|---|
Role of activated intrarenal reactive oxygen species and renin-angiotensin system in IgA nephropathy model mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Blotting, Western; Cyclic N-Oxides; Disease Models, Animal; Glomerulonephritis, IGA; Imidazoles; Immunoglobulin A; Immunohistochemistry; Kidney Glomerulus; Male; Mice; Mice, Inbred Strains; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Spin Labels; Tetrazoles | 2009 |